This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Myeloid malignancies: mutations, models and management
BMC Cancer Open Access 23 July 2012
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Dunbar AJ, Gondek LP, O’Keefe CL, Makishima H, Rataul MS, Szpurka H et al. 250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies. Cancer Res 2008; 68: 10340–10357.
Grand FH, Hidalgo-Curtis CE, Ernst T, Zoi K, Zoi C, McGuire C et al. Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms. Blood 2009; 113: 6182–6192.
Makishima H, Cazzolli H, Szpurka H, Dunbar A, Tiu R, Huh J et al. Mutations of E3 ligase Cbl family members constitute a novel common pathogenic lesion in myeloid malignancies. J Clin Oncol 2009; 27: 6109–6116.
Sanada M, Suzuki T, Shih LY, Otsu M, Kato M, Yamasaki S et al. Gain-of-function of mutated CBL tumour suppressor in myeloid neoplasms. Nature 2009; 460: 904–908.
Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009; 114: 937–951.
Gelsi-Boyer V, Cervera N, Bertucci F, Trouplin V, Rémy V, Olschwang S et al. Genes expression profiling separates chronic myelomonocytic leukaemia in two molecular subtypes. Leukemia 2007; 21: 2359–2362.
Gelsi-Boyer V, Trouplin V, Adélaïde J, Aceto N, Remy V, Pinson S et al. Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes. BMC Cancer 2008; 8: 299–314.
Ohtake F, Baba A, Takada I, Okada M, Iwasaki K, Miki H et al. Dioxin receptor is a ligand-dependent E3 ubiquitin ligase. Nature 2007; 444: 562–566.
Take H, Watanabe S, Takeda K, Yu ZX, Iwata N, Kajigaya S . Cloning and characterization of a novel adaptor protein, CIN85, that interacts with c-Cbl. Biochem Biophys Res Commun 2000; 268: 321–328.
Soubeyran P, Kowanetz K, Szymkiewicz I, Langdon WY, Dikic I . Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors. Nature 2002; 416: 183–187.
Bezsonova I, Bruce MC, Wiesner S, Lin H, Rotin D, Forman-Cay JD . Interactions between the three CIN85 SH3 domains and ubiquitin: implications for CIN85 ubiquitination. Biochemistry 2008; 47: 8937–8949.
Havrylov S, Rzheptskyy Y, Malinowska A, Drobot L, Redowicz MJ . Proteins recruited by the SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS. Protein Sci 2009; 7: 21.
Aissouni Y, Zapart G, Iovanna JL, Dikic I, Soubeyran P . CIN85 regulates the ability of MEKK4 to activate the p38 MAP kinase pathway. Biochem Biophys Res Comm 2005; 338: 808–814.
Langemeijer SM, Kuiper RP, Berends M, Knops R, Aslanyan MG, Massop M et al. Acquired mutations in TET2 are common in myelodysplastic syndromes. Nat Genet 2009; 41: 838–842.
Acknowledgements
This work was supported by Institut Paoli-Calmettes, Inserm, and grants from the Association pour la Recherche contre le Cancer (no. 4992).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Leukemia website
Rights and permissions
About this article
Cite this article
Adélaïde, J., Gelsi-Boyer, V., Rocquain, J. et al. Gain of CBL-interacting protein, a possible alternative to CBL mutations in myeloid malignancies. Leukemia 24, 1539–1541 (2010). https://doi.org/10.1038/leu.2010.135
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2010.135